artesunic acid has been researched along with Ovarian Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; He, L; Li, G; Ling, M; Liu, Q; Mai, Z; Sun, R; Wang, X; Xiao, Y; Yang, W; Yu, K; Yu, Z; Zhong, M | 1 |
| Guo, Y; Guo, Z; Wang, K; Wang, X; Yuan, H; Zhang, S | 1 |
| Bu, S; Guo, Y; Lai, D; Li, B; Sun, J | 1 |
| Chen, X; Gao, YF; Zhang, GH; Zhang, XL | 1 |
| Gong, Y; Guo, H; Hou, D; Liu, J; Liu, Q; Liu, Z; Shao, C; Wang, B; Wei, J; Wu, T; Zhang, X; Zou, Y | 1 |
| Greenshields, AL; Hoskin, DW; Shepherd, TG | 1 |
| Efferth, T; Eichhorn, T; Johnson, SW; Plinkert, PK; Sertel, S; Simon, CH | 1 |
| Chen, HH; Lou, XE; Wu, GD; Zhou, HJ | 1 |
| Chen, HH; Zhou, HJ | 1 |
9 other study(ies) available for artesunic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy.
Topics: Artesunate; Female; Humans; Isosorbide Dinitrate; Nanoparticles; Ovarian Neoplasms; Polymers; Reactive Oxygen Species | 2022 |
Towards rational design of RAD51-targeting prodrugs: platinum
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Drug Design; Female; Humans; Molecular Targeted Therapy; Organoplatinum Compounds; Ovarian Neoplasms; Prodrugs; Rad51 Recombinase | 2018 |
Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest.
Topics: Antimalarials; Artemisinins; Artesunate; Autophagy; Autophagy-Related Protein 5; Carcinoma, Ovarian Epithelial; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; NF-kappa B; Ovarian Neoplasms; RNA Interference; Signal Transduction | 2018 |
Artesunate promotes Th1 differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artesunate; CD4-Positive T-Lymphocytes; Cell Differentiation; Down-Regulation; Female; Flow Cytometry; Mice; Mice, Inbred C57BL; MicroRNAs; Ovarian Neoplasms; Th1 Cells | 2019 |
Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51.
Topics: Animals; Artemisinins; Artesunate; Cell Line, Tumor; Cisplatin; Down-Regulation; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Rad51 Recombinase; Reactive Oxygen Species | 2015 |
Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; G2 Phase; Humans; Mice, Inbred C57BL; Ovarian Neoplasms; Ovary; Reactive Oxygen Species | 2017 |
Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines.
Topics: Artemisinins; Artesunate; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Inhibitory Concentration 50; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Pharmacogenetics; Proto-Oncogene Proteins c-myc | 2010 |
Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Topics: Angiogenesis Inhibitors; Animals; Antimalarials; Artemisinins; Artesunate; Body Weight; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Physiologic; Ovarian Neoplasms; Sesquiterpenes; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Xenograft Model Antitumor Assays | 2004 |
[Inhibitory effects of artesunate on angiogenesis].
Topics: Angiogenesis Inhibitors; Animals; Artemisia; Artemisinins; Artesunate; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Tumor Cells, Cultured; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2 | 2004 |